SEC Form 4 · accession 0001209191-18-021485
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin E Cearnal
Officer — Sr VP/Chief Commercial Officer · Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 23, 2018 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 23, 2018 | A | 5,000 | $6.70 | A | 145,557 | D | |
| Common StockF2 | Mar 23, 2018 | F | 890 | $6.70 | D | 144,667 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on March 20, 2022.
- F2This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.